Search Results - "Teruna J. Siahaan"
-
1
Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles
Published in Scientific reports (09-07-2020)“…Although doxorubicin (DOX) is an effective anti-cancer drug with cytotoxicity in a variety of different tumors, its effectiveness in treating glioblastoma…”
Get full text
Journal Article -
2
Protein PEGylation for cancer therapy: bench to bedside
Published in Journal of cell communication and signaling (01-09-2019)“…PEGylation is a biochemical modification process of bioactive molecules with polyethylene glycol (PEG), which lends several desirable properties to…”
Get full text
Journal Article -
3
Enhancing Antibody Exposure in the Central Nervous System: Mechanisms of Uptake, Clearance, and Strategies for Improved Brain Delivery
Published in Journal of nanotheranostics (02-10-2023)“…Antibodies (mAbs) are attractive molecules for their application as a diagnostic and therapeutic agent for diseases of the central nervous system (CNS). mAbs…”
Get full text
Journal Article -
4
ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells
Published in European journal of pharmaceutical sciences (12-05-2009)“…Interaction of leukocyte function associated antigen-1 (LFA-1) on T-lymphoctytes and intercellular adhesion molecule-1 (ICAM-1) on epithelial cells controls…”
Get full text
Journal Article -
5
M. tuberculosis Transcription Machinery: A Review on the Mycobacterial RNA Polymerase and Drug Discovery Efforts
Published in Life (Basel, Switzerland) (03-11-2022)“…(MTB) is the main source of tuberculosis (TB), one of the oldest known diseases in the human population. Despite the drug discovery efforts of past decades, TB…”
Get full text
Journal Article -
6
Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers
Published in Therapeutic delivery (01-10-2014)“…One of the major hurdles in developing therapeutic agents is the difficulty in delivering drugs through the intestinal mucosa and blood-brain barriers (BBB)…”
Get more information
Journal Article -
7
Methotrexate disposition, anti-folate activity and efficacy in the collagen-induced arthritis mouse model
Published in European journal of pharmacology (15-06-2019)“…Methotrexate (MTX) efficacy in autoimmune arthritis is variable and unpredictable resulting in the need for the identification of biomarkers to guide drug…”
Get full text
Journal Article -
8
Controlling ligand surface density optimizes nanoparticle binding to ICAM-1
Published in Journal of pharmaceutical sciences (01-03-2011)“…During infection, pathogens utilize surface receptors to gain entry into intracellular compartments. Multiple receptor-ligand interactions that lead to…”
Get more information
Journal Article -
9
Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides
Published in Pharmaceutics (31-10-2019)“…Many proteins can be used to treat brain diseases; however, the presence of the blood-brain barrier (BBB) creates an obstacle to delivering them into the…”
Get full text
Journal Article -
10
Conjugates of Cell Adhesion Peptides for Therapeutics and Diagnostics Against Cancer and Autoimmune Diseases
Published in Current topics in medicinal chemistry (01-01-2017)“…Overexpressed cell-surface receptors are hallmarks of many disease states and are often used as markers for targeting diseased cells over healthy counterparts…”
Get more information
Journal Article -
11
Structural Design and Synthesis of Novel Cyclic Peptide Inhibitors Targeting Mycobacterium tuberculosis Transcription
Published in Life (Basel, Switzerland) (28-08-2022)“…Tuberculosis (TB) remains one of the deadliest infectious diseases in the world. Although several established antitubercular drugs have been found, various…”
Get full text
Journal Article -
12
Brain Delivery of Drug and MRI Contrast Agent: Detection and Quantitative Determination of Brain Deposition of CPT-Glu Using LC–MS/MS and Gd-DTPA Using Magnetic Resonance Imaging
Published in Molecular pharmaceutics (01-02-2016)“…Successful treatment and diagnosis of neurological diseases depend on reliable delivery of molecules across the blood–brain barrier (BBB), which restricts…”
Get full text
Journal Article -
13
Inhibition of LFA-1/ICAM-1 and VLA-4/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases
Published in Medicinal research reviews (01-03-2002)“…This review focuses on providing insights into the structural basis and clinical relevance of LFA‐1 and VLA‐4 inhibition by peptides and small molecules as…”
Get full text
Journal Article -
14
Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors
Published in Pharmaceutics (17-09-2019)“…The blood-brain barrier (BBB) poses a major obstacle by preventing potential therapeutic agents from reaching their intended brain targets at sufficient…”
Get full text
Journal Article -
15
Peptide-mediated targeted drug delivery
Published in Medicinal research reviews (01-05-2012)“…Targeted drug delivery to specific group of cells offers an attractive strategy to minimize the undesirable side effects and achieve the therapeutic effect…”
Get full text
Journal Article -
16
Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors
Published in Peptides (01-03-2003)“…This review describes the role of modulation of intracellular adhesion molecule-1 (ICAM-1)/leukocyte function-associated antigen-1 (LFA-1) interaction in…”
Get full text
Book Review Journal Article -
17
Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor
Published in The Journal of pharmacology and experimental therapeutics (01-08-2007)“…The objective of this study is to evaluate the activity of a novel peptide, i.e., bifunctional peptide inhibitor (BPI), which targets the immunological synapse…”
Get more information
Journal Article -
18
Improving Brain Delivery of Biomolecules via BBB Modulation in Mouse and Rat: Detection using MRI, NIRF, and Mass Spectrometry
Published in Nanotheranostics (Sydney, NSW) (2017)“…There is an urgent need to develop new and alternative methods to deliver functional biomolecules to the brain for diagnosis and treatment of brain diseases…”
Get full text
Journal Article -
19
Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitis
Published in Molecular therapy. Methods & clinical development (01-01-2014)“…Autoimmune diseases such as multiple sclerosis (MS) are typified by the misrecognition of self-antigen and the clonal expansion of autoreactive T cells…”
Get full text
Journal Article -
20
Noninvasive Brain Delivery and Efficacy of BDNF to Stimulate Neuroregeneration and Suppression of Disease Relapse in EAE Mice
Published in Molecular pharmaceutics (03-02-2020)“…The number of FDA-approved protein drugs (biologics), such as antibodies, antibody–drug conjugates, hormones, and enzymes, continues to grow at a rapid rate;…”
Get full text
Journal Article